Results 1 to 10 of about 7,629 (157)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern [PDF]

BMC Women's Health, 2018
Background Vulvovaginal candidiasis is a global issue of concern due to its association with economic costs, sexually transmitted infections, and ascending genital tract infection.
Adane Bitew, Yeshiwork Abebaw
doaj   +2 more sources

Non-albicans Candida in Vulvovaginal Candidiasis: Antifungal Resistance and Expression of ERG11, CDR1, CDR2, and MDR1 Genes. [PDF]

Microbiologyopen
The rise in azole resistance among Nakaseomyces glabratus and Pichia kudriavzevii presents a growing public health challenge. These results indicate that even in cases where an isolate is classified as susceptible by drug susceptibility testing, elevated gene expression may persist, and treatment should not be discontinued.
Ranjbar Golafshani FZ, Kermani F, Abbaszadeh Godarzi S, Mahdavi Omran S.   +3 more
europepmc   +2 more sources

The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis [PDF]

Гинекология, 2017
Host immunity against Candida albicans is crucial in controlling C. albicans infection. The innate immunity is believed to be the first line of host defense, such as the direct killing of yeasts through phagocytosis by neutrophils and macrophages.
Sh M Pogosyan, E A Mezhevitinova, P R Abakarova, A E Donnikov, V V Muravyova   +4 more
doaj   +2 more sources

Fluconazole-resistant vulvovaginal candidiasis in reproductive-age women: a study from Himalayan country [PDF]

BMC Microbiology
Background Vulvovaginal candidiasis is the second most common fungal infections among reproductive-age women. These conditions are commonly treated with the azole derivatives administered locally or systemically, most commonly fluconazole (FCZ).
Deepshikha Yadav, Purnima Baidya, Prabhakar R. Panday, Pritee Yadav, Kul R. Rai, Prasha Shrestha, Manita Aryal   +6 more
doaj   +2 more sources

Recurrent vulvovaginal candidiasis associated with the use of a probiotic supplement [PDF]

IDCases
Background: Recurrent vulvovaginal candidiasis (RVVC) is a common cause of morbidity in women with vulvovaginal complaints. Saccharomyces species have been shown to cause vulvovaginal candidiasis in only 2 % - 6 % of RVVC cases. However, these infections
Chemen M. Neal, Andrea I. Gonzalez, Adeoti Oshinowo, Trilliah Fazle, Tavonna Kako   +4 more
doaj   +2 more sources

Rational treatment for vulvovaginal candidiasis caused by resistant Candida species [PDF]

РМЖ. Мать и дитя, 2019
G.B. Dikke F.I. Inozemtsev Academy of Medical Education, St. Petersburg, Russian Federation In recent decade, growing incidence (24–29%) of vulvovaginal candidiasis caused by Candida non-albicans is reported.
G.B. Dikke
doaj   +1 more source

Vulvovaginal Candidiasis Among American Indian and Alaska Native People, Indian Health Service, 2016-2022. [PDF]

Public Health Rep
Benedict K, Kennedy JL, Smith DJ, Haberling DL, Chukwuma U.   +4 more
europepmc   +3 more sources

Efficacy of fermented foods for the prevention and treatment of bacterial vaginosis and vulvovaginal candidiasis. [PDF]

Front Nutr
Akpınar A, Markiewicz LH, Harsa HŞ, Paveljšek D, Domínguez-Soberanes J, Agirbasli Z, Naziri E, El Jalil MH, Bouchaud G, Salminen S, Savary-Auzeloux I, Humblot C, Chassard C, Pracer S, Vergères G, Karakaş-Budak B.   +15 more
europepmc   +3 more sources

Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis

SAGE Open Medicine, 2022
Vulvovaginal candidiasis is a common infection associated most often with the overgrowth of the fungal species Candida albicans . Although most women will have at least one episode of vulvovaginal candidiasis in their lifetime, some will experience ...
Chemen M Neal, Mark G Martens
doaj   +1 more source

Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp

Journal of Investigative Medicine High Impact Case Reports, 2022
Recurrent vulvovaginal candidiasis is a common disorder which causes significant morbidity among women worldwide, and treatment options are limited.
Leah M. Grant MD, Robert Orenstein DO
doaj   +1 more source